| stavudine / Generic mfg. |
NCT00002308: A Study of Stavudine in HIV-Infected Patients Who Have Not Had Success With Other Anti-HIV Drugs |
|
|
| Completed | N/A | | US | Stavudine | Bristol-Myers Squibb | HIV Infections | | 11/91 | | |
NCT00002307: A Comparison of Zidovudine (AZT) and Stavudine in HIV-Infected Patients |
|
|
| Completed | N/A | | US | Stavudine, Zidovudine | Bristol-Myers Squibb | HIV Infections | | 12/94 | | |
NCT00002349: A Pilot Study to Compare the Antiviral and Immunologic Effects of Stavudine ( d4T ) Versus Placebo in Subjects With Evidence of Recent HIV Infection. |
|
|
| Completed | N/A | 40 | US | Stavudine | Bristol-Myers Squibb | HIV Infections | 05/99 | 05/99 | | |
NCT00002176: A Pilot Open Label Trial of HIV Therapy With d4T (Stavudine), ddI (Didanosine), Nelfinavir and Hydroxyurea in Subjects With Early Asymptomatic HIV Infection |
|
|
| Completed | N/A | | US | Hydroxyurea, Nelfinavir mesylate, Stavudine, Didanosine | Bristol-Myers Squibb | HIV Infections | 03/00 | 03/00 | | |
NCT00002177: A Pilot Open Label Trial of HIV Therapy With d4T (Stavudine), ddI (Didanosine), Nelfinavir and Hydroxyurea in Subjects With Recent HIV Infection |
|
|
| Completed | N/A | | US | Hydroxyurea, Nelfinavir mesylate, Stavudine, Didanosine | Bristol-Myers Squibb | HIV Infections | 03/00 | 03/00 | | |
NCT00002207: A Comparison of Two Dose Levels of Didanosine Used in Combination With Stavudine in HIV-Infected Patients |
|
|
| Completed | N/A | | US | Stavudine, Didanosine | Bristol-Myers Squibb | HIV Infections | 02/04 | 02/04 | | |
NCT00002168: A Comparison of Two Anti-HIV Triple-Drug Combinations in HIV-Infected Patients |
|
|
| Completed | N/A | 200 | US | Indinavir sulfate, Lamivudine, Stavudine, Zidovudine, Didanosine | Bristol-Myers Squibb | HIV Infections | | | | |
NCT00002369: A Comparison of Epivir Plus Crixivan Combined With Zerit or Retrovir in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs |
|
|
| Completed | N/A | 200 | US | Indinavir sulfate, Lamivudine, Stavudine, Zidovudine | Bristol-Myers Squibb | HIV Infections | | | | |
